VIRP.PA
Price:
$353.5
Market Cap:
$2.94B
Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.[Read more]
Industry
Drug Manufacturers - General
IPO Date
1992-07-07
Stock Exchange
EURONEXT
Ticker
VIRP.PA
According to Virbac SA’s latest financial reports and current stock price. The company's current PE Ratio is 20.99. This represents a change of 100.30% compared to the average of 10.48 of the last 4 quarters.
The mean historical PE Ratio of Virbac SA over the last ten years is 3.21. The current 20.99 PE Ratio has changed 65.38% with respect to the historical average. Over the past ten years (40 quarters), VIRP.PA's PE Ratio was at its highest in in the December 2015 quarter at 35.03. The PE Ratio was at its lowest in in the June 2015 quarter at -105.78.
Average
3.21
Median
28.13
Minimum
-401.94
Maximum
197.02
Discovering the peaks and valleys of Virbac SA PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 752.74%
Maximum Annual PE Ratio = 197.02
Minimum Annual Increase = -1088.09%
Minimum Annual PE Ratio = -401.94
Year | PE Ratio | Change |
---|---|---|
2023 | 24.58 | 55.63% |
2022 | 15.79 | -50.16% |
2021 | 31.69 | 114.69% |
2020 | 14.76 | -61.84% |
2019 | 38.68 | -18.88% |
2018 | 47.69 | -111.86% |
2017 | -401.94 | -1088.09% |
2016 | 40.68 | -79.35% |
2015 | 197.02 | 752.74% |
2014 | 23.10 | 6.84% |
The current PE Ratio of Virbac SA (VIRP.PA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
24.02
5-year avg
25.10
10-year avg
3.21
Virbac SA’s PE Ratio is greater than Vetoquinol SA (19.72), greater than Trigano S.A. (6.58), less than bioMérieux S.A. (29.50), less than Sartorius Stedim Biotech S.A. (108.15), greater than Ipsen S.A. (13.15),
Company | PE Ratio | Market cap |
---|---|---|
19.72 | $928.78M | |
6.58 | $2.41B | |
29.50 | $12.13B | |
108.15 | $18.12B | |
13.15 | $9.26B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Virbac SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Virbac SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Virbac SA's PE Ratio?
How is the PE Ratio calculated for Virbac SA (VIRP.PA)?
What is the highest PE Ratio for Virbac SA (VIRP.PA)?
What is the 3-year average PE Ratio for Virbac SA (VIRP.PA)?
What is the 5-year average PE Ratio for Virbac SA (VIRP.PA)?
How does the current PE Ratio for Virbac SA (VIRP.PA) compare to its historical average?